Senior Health Economist

Company: Consult
Apply for the Senior Health Economist
Location: Reading
Job Description:

ROLE PROFILE

To effectively demonstrate and communicate the value of an allocated product portfolio to national payers thereby removing barriers to market access, via a proactive in-house approach to Health Economics.

TASKS & RESPONSIBILITIES

  • Leads the development, review and refinement of UK/Ireland National Market Access Plans for products in collaboration with various internal stakeholders
  • Recommends the optimal HTA strategy and leads all aspects of the HTA process for allocated products in UK/Ireland, a business critical process for achieving market access
  • Takes a prominent role in cross-functional Franchise teams and is a recognised authority, ensuring that Market Access is integral to brand strategy and tactics
  • Proactively produces and disseminates high quality materials that communicate the value of products to national payers.
  • Conversant and fully compliant with ABPI and IPHA codes of practice and SOPs
  • Timely and accurate delivery of horizon scanning information on pipeline products. Ensuring Market Access input during early stage product development and assessment
  • In depth technical knowledge of HE modelling and value communication & implementation using a variety of channels
  • Demonstrates Centre Of Excellence behaviours by providing leading input to, and adaptation of (where appropriate), Corporate HEOR materials ensuring they are fit-for-purpose and relevant to the UK/Ireland setting and the ABPI code of practice. Commissioning and managing large projects with third-party vendors and both internal and external stakeholders. Fosters the in-house development and training of other health economists

REQUIREMENTS

  • At least MSc in Health Economics or equivalent discipline
  • Able to work at a strategic level within cross functional teams
  • Good working knowledge and practical experience of

o all methods of economic evaluation

o the requirements and processes of HTA bodies including NICE and the SMC

o UK and Ireland market access barriers

o development of payer materials that can be used to support market access

o training cross-functional teams (informal)

Posted: September 7th, 2024